The Vaccibody Vaccine Technology Platform has the potential to overcome the challenges faced in today’s vaccine development through rational and innovative design. Vaccibody’s vaccines are based on thorough understanding of the immunological principles and physiological mechanisms:
Vaccibody vaccines can direct the immune response in an optimal manner by specifically targeting Antigen Presenting Cells (APC), known to be essential to initiate an effective immune response.
By intelligent design Vaccibody vaccines are tailored to induce the desired immune response profile for each specific disease with any given antigen.
The flexibility of Vaccibody’s Vaccine Technology Platform offers the possibility to develop vaccines to treat or prevent infectious diseases and cancers. The vaccines are applicable for both human and veterinary use.